Glycaemic Control and Hormone Replacement Therapy: Implications of the Postmenopausal Estrogen/Progestogen Intervention (PEPI) Study

Author： Fineberg S.E.  

Publisher： Adis International

ISSN： 1170-229X

Source： Drugs & Aging, Vol.17, Iss.6, 2000-12, pp. : 453-461

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Monophasic Estrogen-Progestogen Therapy and Sexuality in Postmenopausal Women

By Fonseca A.M.   Bagnoli V.R.   Penteado S.R.L.   Paixão J.S.   Cavalcanti A.L.   Pinotti J.A.  

Clinical Drug Investigation, Vol. 27, Iss. 2, 2007-01 ,pp. : 131-137

Adis International

Access to resources Recommend Favorite

Combination of Intermittent Cyclical Etidronate and Hormone Replacement Therapy for Postmenopausal Non-Responders to Estrogen

By Nozaki M.   Koera K.   Egami R.   Nagata H.   Nakano H.  

Clinical Drug Investigation, Vol. 22, Iss. 2, 2002-01 ,pp. : 111-117

Adis International

Access to resources Recommend Favorite

Estrogen/progestogen fails to enhance QOL

By  

Inpharma, Vol. 1, Iss. 1379, 2003-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Estrogen/progestogen fails to enhance QOL

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 404, 2003-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Estrogen/progestogen: decreased colorectal cancer risk

By  

Inpharma, Vol. 1, Iss. 1428, 2004-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite